CAT and urinary bladder carcinoma: Our previous results and related studies showed that the PPARγ can disrupt the homeostasis of ROS metabolism in bladder cancer by affecting the expression of antioxidant enzymes (catalase and SOD2), thereby affecting the occurrence and progression of bladder cancer 8, 9.